October 18, 2017October 18, 2017

Incysus Advances T-Cell Therapy into Phase 1 Trial for Blood Cancers

News

Incysus and the University of Alabama at Birmingham (UAB) are advancing the company’s investigational gamma-delta (γδ) T-cell therapy into a Phase 1 clinical study for the treatment of leukemia and lymphoma ... Read more

October 2, 2017October 2, 2017

Incysus Seeks FDA Approval to Start Blood Cancer Trials for Its γδ T-Cell Immunotherapy

News

Incysus has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) to start clinical development of its expanded and activated allogeneic gamma-delta (γδ) T-cell ... Read more